Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-11

Clinical Trial Update: Platelet Rich Plasma in the Prevention of Adhesion Reformation [NA]

View source ↗

Summary

This clinical trial update shows enrollment by invitation for using platelet-rich plasma to prevent adhesion reformation in intrauterine adhesion (Asherman synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Fu Xing Hospital, Capital Medical University | Conditions: Intrauterine Adhesion, Asherman Syndrome | NA | Status: ENROLLING_BY_INVITATION